HOX Genes in High Grade Ovarian Cancer

Cancers - Switzerland
doi 10.3390/cancers11081107
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

New in High Grade Serous Ovarian Cancer Treatment

Effective Pharmacotherapy
2019English

Identification of Candidate Genes Associated With Tubal Origin of High‑grade Serous Ovarian Cancer

Oncology Letters
Cancer ResearchOncology
2018English

PARP Inhibitors in Platinum-Sensitive High-Grade Serous Ovarian Cancer

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2018English

Molecular Abnormalities in Ovarian Cancer Subtypes Other Than High-Grade Serous Carcinoma

Journal of Oncology
Oncology
2010English

Targeting IDH1 as a Pro-Senescent Therapy in High-Grade Serous Ovarian Cancer

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2019English

Role of HOX Genes in Stem Cell Differentiation and Cancer

Stem Cells International
Cell BiologyMolecular Biology
2018English

Predictors of Long-Term Survival Among High-Grade Serous Ovarian Cancer Patients

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2019English

Integrated Analysis to Identify Molecular Biomarkers of High-Grade Serous Ovarian Cancer

OncoTargets and Therapy
OncologyPharmacology
2019English

Clinical Impact of Somatic Variants in Homologous Recombination Repair-Related Genes in Ovarian High-Grade Serous Carcinoma

Cancer Research and Treatment
Cancer ResearchOncology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy